Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.


Contact Us >>

WhatsApp  +86 18163351462(WhatsApp)
Paper Publishing WeChat
Book Publishing WeChat
(or Email:book@scirp.org)

Article citations


R. S. Wilson, S. E. Arnold, J. A. Schneider, P. A. Boyle, A. S. Buchman and D. A. Bennett, “Olfactory Impairment in Presymptomatic Alzheimer’s Disease,” Annals of the New York Academy of Sciences, Vol. 1170, 2009, pp. 730-735. doi:10.1111/j.1749-6632.2009.04013.x

has been cited by the following article:

  • TITLE: Modification of the Brief Smell Identification Test by Introduction of a Placebo

    AUTHORS: Grete Kjelvik, Ole Bosnes, Ragnhild Omli, Liv Heidi Skotnes, Asta K. Håberg, Linda R. White

    KEYWORDS: B-SIT; Odor Identification; Scratch and Sniff Tests; Norwegian Population; Olfactory Testing; Neurodegenerative Diseases

    JOURNAL NAME: Neuroscience and Medicine, Vol.3 No.2, June 8, 2012

    ABSTRACT: Objective: To introduce the concept that there might be “nothing to smell” to the Brief Smell Identification Test (B-SIT), with a view to masking olfactory deficits, particularly from healthy control participants in research studies. Methods: Seventy-one elderly individuals, healthy for their age, were recruited to the study. They were blindfolded and carried out a modified B-SIT where one item had been replaced with a placebo, and one odour alternative answer to three other items was replaced by the alternative “none/other” (actual odour unchanged). Results: There was no overall difference in the median or mean score achieved by the cohort compared to results obtained previously using the conventional B-SIT. The replacement of the item “turpentine” with a placebo resulted in an improved score for the item in a Norwegian setting. The overall scores were not improved. Conclusions: It is possible to introduce the concept that there may be “nothing to smell” to the B-SIT without compromising the test for healthy control individuals. This may be a more appropriate approach to olfactory testing of control individuals or patients with suspected early neurodegenerative diseases.